Evogene (EVGN) Tops Q1 EPS by 26c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.06), $0.26 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $334 thousand versus the consensus estimate of $3 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval